Amélie holds a Master’s degree (MSc) in Immunology from Université de Montréal and a PhD in Experimental Medicine from McGill University. She also graduated from the Executive MBA program of the HEC and McGill University in 2021.
Amélie has been working in the pharmaceutical industry for the past twenty years. She has acquired diverse experience in several roles, including clinical and basic research, on the medical side, as well as in sales and marketing.
Amélie joined JAMP Pharma Group in January 2022 as Director of the Hospital Division, which became JAMP Acute Care and Injectables in 2023. She was promoted to Vice President, Hospital Affairs and Specialty Products in 2023, with responsibility for managing the Patient Support Programs (PSP).
Amélie’s mission is to make JAMP Pharma a Canadian leader in both injectables and specialty products, and to implement outstanding patient support programs.
“I’m proud to be part of a Canadian company, to be able to contribute to its growth every day, to enable Canadian patients to have access to programs that stand out, and to contribute to a better healthcare system.”
